Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Glycogen storage disease type 1a is associated with disturbed vitamin A metabolism and elevated serum retinol levels.

Saeed A, Hoogerland JA, Wessel H, Heegsma J, Derks TGJ, van der Veer E, Mithieux G, Rajas F, Oosterveer MH, Faber KN.

Hum Mol Genet. 2020 Jan 15;29(2):264-273. doi: 10.1093/hmg/ddz283.

2.

Contribution of bone marrow-derived cells to in situ engineered tissue capsules in a rat model of chronic kidney disease.

Bezhaeva T, Geelhoed WJ, Wang D, Yuan H, van der Veer EP, Alem CMAV, Damanik FFR, Qiu X, Zonneveld AV, Moroni L, Li S, Rotmans JI.

Biomaterials. 2019 Feb;194:47-56. doi: 10.1016/j.biomaterials.2018.12.014. Epub 2018 Dec 15.

PMID:
30580195
3.

Relaxin receptor deficiency promotes vascular inflammation and impairs outward remodeling in arteriovenous fistulas.

Bezhaeva T, de Vries MR, Geelhoed WJ, van der Veer EP, Versteeg S, van Alem CMA, Voorzaat BM, Eijkelkamp N, van der Bogt KE, Agoulnik AI, van Zonneveld AJ, Quax PHA, Rotmans JI.

FASEB J. 2018 Jun 8:fj201800437R. doi: 10.1096/fj.201800437R. [Epub ahead of print]

PMID:
29882709
4.

MicroRNA-132 controls water homeostasis through regulating MECP2-mediated vasopressin synthesis.

Bijkerk R, Trimpert C, van Solingen C, de Bruin RG, Florijn BW, Kooijman S, van den Berg R, van der Veer EP, Bredewold EOW, Rensen PCN, Rabelink TJ, Humphreys BD, Deen PMT, van Zonneveld AJ.

Am J Physiol Renal Physiol. 2018 Oct 1;315(4):F1129-F1138. doi: 10.1152/ajprenal.00087.2018. Epub 2018 May 30.

5.

Ankylosing spondylitis disease activity score is related to NSAID use, especially in patients treated with TNF-α inhibitors.

Carbo MJG, Spoorenberg A, Maas F, Brouwer E, Bos R, Bootsma H, van der Veer E, Wink F, Arends S.

PLoS One. 2018 Apr 24;13(4):e0196281. doi: 10.1371/journal.pone.0196281. eCollection 2018.

6.

No indications for platelet activation in acute clinical myocardial or renal ischemia/reperfusion injury.

Kortekaas KA, de Vries DK, Roest M, Reinders ME, van der Veer EP, Klautz RJ, de Groot PG, Schaapherder AF, Lindeman JH.

Am J Transl Res. 2018 Mar 15;10(3):816-826. eCollection 2018.

7.

A dedicated Fracture Liaison Service telephone program and use of bone turnover markers for evaluating 1-year persistence with oral bisphosphonates.

van den Berg P, van Haard PMM, van der Veer E, Geusens PP, van den Bergh JP, Schweitzer DH.

Osteoporos Int. 2018 Apr;29(4):813-824. doi: 10.1007/s00198-017-4340-5. Epub 2017 Dec 19.

PMID:
29260291
8.

Gender and cardiovascular disease: are sex-biased microRNA networks a driving force behind heart failure with preserved ejection fraction in women?

Florijn BW, Bijkerk R, van der Veer EP, van Zonneveld AJ.

Cardiovasc Res. 2018 Feb 1;114(2):210-225. doi: 10.1093/cvr/cvx223. Review.

PMID:
29186452
9.

Local delivery of liposomal prednisolone leads to an anti-inflammatory profile in renal ischaemia-reperfusion injury in the rat.

van Alem CMA, Boonstra M, Prins J, Bezhaeva T, van Essen MF, Ruben JM, Vahrmeijer AL, van der Veer EP, de Fijter JW, Reinders ME, Meijer O, Metselaar JM, van Kooten C, Rotmans JI.

Nephrol Dial Transplant. 2018 Jan 1;33(1):44-53. doi: 10.1093/ndt/gfx204.

PMID:
28992069
10.

Deficiency of TLR4 homologue RP105 aggravates outward remodeling in a murine model of arteriovenous fistula failure.

Bezhaeva T, Wong C, de Vries MR, van der Veer EP, van Alem CMA, Que I, Lalai RA, van Zonneveld AJ, Rotmans JI, Quax PHA.

Sci Rep. 2017 Aug 31;7(1):10269. doi: 10.1038/s41598-017-10108-4.

11.

[Diagnosis and treatment of orbital cellulitis].

van der Poel NA, van der Veer EG, Ebbens FA, de Win MM, Kloos RJ, Mourits MP.

Ned Tijdschr Geneeskd. 2017;161:D1342. Review. Dutch.

PMID:
28745248
12.

Osteoporosis and osteopenia are not associated with T-cell activation in older cART-treated HIV-infected patients.

Krikke M, Klomberg RCW, van der Veer E, Tesselaar K, Verhaar HJJ, Hoepelman AIM, Arends JE.

Neth J Med. 2017 May;75(4):138-144.

13.

Ultrasound Evaluation of the Entheses in Daily Clinical Practice during Tumor Necrosis Factor-α Blocking Therapy in Patients with Ankylosing Spondylitis.

Wink F, Bruyn GA, Maas F, Griep EN, van der Veer E, Bootsma H, Brouwer E, Arends S, Spoorenberg A.

J Rheumatol. 2017 May;44(5):587-593. doi: 10.3899/jrheum.160584. Epub 2017 Mar 15.

PMID:
28298566
14.

Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial.

van der Ree MH, de Vree JM, Stelma F, Willemse S, van der Valk M, Rietdijk S, Molenkamp R, Schinkel J, van Nuenen AC, Beuers U, Hadi S, Harbers M, van der Veer E, Liu K, Grundy J, Patick AK, Pavlicek A, Blem J, Huang M, Grint P, Neben S, Gibson NW, Kootstra NA, Reesink HW.

Lancet. 2017 Feb 18;389(10070):709-717. doi: 10.1016/S0140-6736(16)31715-9. Epub 2017 Jan 11.

PMID:
28087069
15.

Emerging roles for RNA-binding proteins as effectors and regulators of cardiovascular disease.

de Bruin RG, Rabelink TJ, van Zonneveld AJ, van der Veer EP.

Eur Heart J. 2017 May 7;38(18):1380-1388. doi: 10.1093/eurheartj/ehw567. Review.

PMID:
28064149
16.

Elevated Bone Turnover Markers after Risk-Reducing Salpingo-Oophorectomy in Women at Increased Risk for Breast and Ovarian Cancer.

Fakkert IE, van der Veer E, Abma EM, Lefrandt JD, Wolffenbuttel BH, Oosterwijk JC, Slart RH, Westrik IG, de Bock GH, Mourits MJ.

PLoS One. 2017 Jan 6;12(1):e0169673. doi: 10.1371/journal.pone.0169673. eCollection 2017.

17.

Radiographic damage and progression of the cervical spine in ankylosing spondylitis patients treated with TNF-α inhibitors: Facet joints vs. vertebral bodies.

Maas F, Spoorenberg A, Brouwer E, van der Veer E, Bootsma H, Bos R, Wink FR, Arends S.

Semin Arthritis Rheum. 2017 Apr;46(5):562-568. doi: 10.1016/j.semarthrit.2016.11.003. Epub 2016 Nov 9.

PMID:
28040243
18.

True abscess formation is rare in bacterial orbital cellulitis; consequences for treatment.

Van der Veer EG, van der Poel NA, de Win MM, Kloos RJ, Saeed P, Mourits MP.

Am J Otolaryngol. 2017 Mar - Apr;38(2):130-134. doi: 10.1016/j.amjoto.2016.11.006. Epub 2016 Nov 24.

PMID:
27914713
19.

Long-term drug survival and clinical effectiveness of etanercept treatment in patients with ankylosing spondylitis in daily clinical practice.

Arends S, Brouwer E, Efde M, van der Veer E, Bootsma H, Wink F, Spoorenberg A.

Clin Exp Rheumatol. 2017 Jan-Feb;35(1):61-68. Epub 2016 Oct 7.

PMID:
27749222
20.

Reduction in Spinal Radiographic Progression in Ankylosing Spondylitis Patients Receiving Prolonged Treatment With Tumor Necrosis Factor Inhibitors.

Maas F, Arends S, Brouwer E, Essers I, van der Veer E, Efde M, van Ooijen PMA, Wolf R, Veeger NJGM, Bootsma H, Wink FR, Spoorenberg A.

Arthritis Care Res (Hoboken). 2017 Jul;69(7):1011-1019. doi: 10.1002/acr.23097. Epub 2017 Jun 9.

21.

Promoting Tropoelastin Expression in Arterial and Venous Vascular Smooth Muscle Cells and Fibroblasts for Vascular Tissue Engineering.

Rothuizen TC, Kemp R, Duijs JM, de Boer HC, Bijkerk R, van der Veer EP, Moroni L, van Zonneveld AJ, Weiss AS, Rabelink TJ, Rotmans JI.

Tissue Eng Part C Methods. 2016 Oct;22(10):923-931. doi: 10.1089/ten.TEC.2016.0173. Epub 2016 Sep 28.

PMID:
27604583
22.

Clinical Risk Factors for the Presence and Development of Vertebral Fractures in Patients With Ankylosing Spondylitis.

Maas F, Spoorenberg A, van der Slik BPG, van der Veer E, Brouwer E, Bootsma H, Bos R, Wink FR, Arends S.

Arthritis Care Res (Hoboken). 2017 May;69(5):694-702. doi: 10.1002/acr.22980.

23.

Silencing of microRNA-132 reduces renal fibrosis by selectively inhibiting myofibroblast proliferation.

Bijkerk R, de Bruin RG, van Solingen C, van Gils JM, Duijs JM, van der Veer EP, Rabelink TJ, Humphreys BD, van Zonneveld AJ.

Kidney Int. 2016 Jun;89(6):1268-80. doi: 10.1016/j.kint.2016.01.029. Epub 2016 Apr 8.

PMID:
27165825
24.

Genetic Susceptibility and Predictors of Paradoxical Reactions in Buruli Ulcer.

Barogui YT, Klis SA, Johnson RC, Phillips RO, van der Veer E, van Diemen C, van der Werf TS, Stienstra Y.

PLoS Negl Trop Dis. 2016 Apr 20;10(4):e0004594. doi: 10.1371/journal.pntd.0004594. eCollection 2016 Apr.

25.

Quaking promotes monocyte differentiation into pro-atherogenic macrophages by controlling pre-mRNA splicing and gene expression.

de Bruin RG, Shiue L, Prins J, de Boer HC, Singh A, Fagg WS, van Gils JM, Duijs JM, Katzman S, Kraaijeveld AO, Böhringer S, Leung WY, Kielbasa SM, Donahue JP, van der Zande PH, Sijbom R, van Alem CM, Bot I, van Kooten C, Jukema JW, Van Esch H, Rabelink TJ, Kazan H, Biessen EA, Ares M Jr, van Zonneveld AJ, van der Veer EP.

Nat Commun. 2016 Mar 31;7:10846. doi: 10.1038/ncomms10846.

26.

The RNA-binding protein quaking maintains endothelial barrier function and affects VE-cadherin and β-catenin protein expression.

de Bruin RG, van der Veer EP, Prins J, Lee DH, Dane MJ, Zhang H, Roeten MK, Bijkerk R, de Boer HC, Rabelink TJ, van Zonneveld AJ, van Gils JM.

Sci Rep. 2016 Feb 24;6:21643. doi: 10.1038/srep21643.

27.

Radiographic vertebral fractures develop in patients with ankylosing spondylitis during 4 years of TNF-α blocking therapy.

Maas F, Spoorenberg A, Brouwer E, Schilder AM, Chaudhry RN, Wink F, Bootsma H, van der Veer E, Arends S.

Clin Exp Rheumatol. 2016 Mar-Apr;34(2):191-9. Epub 2016 Feb 9.

PMID:
26886385
28.

Modeling the combined effect of RNA-binding proteins and microRNAs in post-transcriptional regulation.

HafezQorani S, Lafzi A, de Bruin RG, van Zonneveld AJ, van der Veer EP, Son YA, Kazan H.

Nucleic Acids Res. 2016 May 19;44(9):e83. doi: 10.1093/nar/gkw048. Epub 2016 Feb 2.

29.

Obesity Is Common in Axial Spondyloarthritis and Is Associated with Poor Clinical Outcome.

Maas F, Arends S, van der Veer E, Wink F, Efde M, Bootsma H, Brouwer E, Spoorenberg A.

J Rheumatol. 2016 Feb;43(2):383-7. doi: 10.3899/jrheum.150648. Epub 2015 Dec 15.

PMID:
26669924
30.

Male and female patients with axial spondyloarthritis experience disease activity, physical function and quality of life differently: results from the Groningen Leeuwarden Axial Spondyloarthritis cohort.

Arends S, Maas F, Wink F, Efde M, Bootsma H, van der Veer E, Brouwer E, Spoorenberg A.

Rheumatology (Oxford). 2015 Jul;54(7):1333-5. doi: 10.1093/rheumatology/kev119. Epub 2015 May 3. No abstract available.

PMID:
25936792
31.

Spinal radiographic progression in patients with ankylosing spondylitis treated with TNF-α blocking therapy: a prospective longitudinal observational cohort study.

Maas F, Spoorenberg A, Brouwer E, Bos R, Efde M, Chaudhry RN, Veeger NJ, van Ooijen PM, Wolf R, Bootsma H, van der Veer E, Arends S.

PLoS One. 2015 Apr 16;10(4):e0122693. doi: 10.1371/journal.pone.0122693. eCollection 2015.

32.

Patient-tailored dose reduction of TNF-α blocking agents in ankylosing spondylitis patients with stable low disease activity in daily clinical practice.

Arends S, van der Veer E, Kamps FB, Houtman PM, Bos R, Bootsma H, Brouwer E, Spoorenberg A.

Clin Exp Rheumatol. 2015 Mar-Apr;33(2):174-80. Epub 2015 Mar 10.

PMID:
25797228
33.

Silencing of miRNA-126 in kidney ischemia reperfusion is associated with elevated SDF-1 levels and mobilization of Sca-1+/Lin- progenitor cells.

Bijkerk R, van Solingen C, de Boer HC, de Vries DK, Monge M, van Oeveren-Rietdijk A, van der Veer EP, Schaapherder AF, Rabelink TJ, van Zonneveld AJ.

Microrna. 2014;3(3):144-9.

PMID:
25541911
34.

Bone mineral density and fractures after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancer.

Fakkert IE, Abma EM, Westrik IG, Lefrandt JD, Wolffenbuttel BH, Oosterwijk JC, Slart RH, van der Veer E, de Bock GH, Mourits MJ.

Eur J Cancer. 2015 Feb;51(3):400-8. doi: 10.1016/j.ejca.2014.11.022. Epub 2014 Dec 18.

35.

In vitro antiviral activity and preclinical and clinical resistance profile of miravirsen, a novel anti-hepatitis C virus therapeutic targeting the human factor miR-122.

Ottosen S, Parsley TB, Yang L, Zeh K, van Doorn LJ, van der Veer E, Raney AK, Hodges MR, Patick AK.

Antimicrob Agents Chemother. 2015 Jan;59(1):599-608. doi: 10.1128/AAC.04220-14. Epub 2014 Nov 10.

36.

Diminished reliability of tryptase as risk indicator of mastocytosis in older overweight subjects.

Vos BJ, van der Veer E, van Voorst Vader PC, Mulder AB, van der Heide S, Arends S, Kluin-Nelemans JC, de Monchy JG, van Doormaal JJ, Oude Elberink JN.

J Allergy Clin Immunol. 2015 Mar;135(3):792-8. doi: 10.1016/j.jaci.2014.05.047. Epub 2014 Aug 13.

PMID:
25129675
37.

Predictors of new fragility fractures after diagnosis of indolent systemic mastocytosis.

van der Veer E, Arends S, van der Hoek S, Versluijs JB, de Monchy JGR, Oude Elberink JNG, van Doormaal JJ.

J Allergy Clin Immunol. 2014 Dec;134(6):1413-1421. doi: 10.1016/j.jaci.2014.05.003. Epub 2014 Jun 27.

PMID:
24985401
38.

Higher bone turnover is related to spinal radiographic damage and low bone mineral density in ankylosing spondylitis patients with active disease: a cross-sectional analysis.

Arends S, Spoorenberg A, Efde M, Bos R, Leijsma MK, Bootsma H, Veeger NJ, Brouwer E, van der Veer E.

PLoS One. 2014 Jun 11;9(6):e99685. doi: 10.1371/journal.pone.0099685. eCollection 2014.

39.

Procollagen type I N-terminal peptide in preterm infants is associated with growth during the first six months post-term.

van de Lagemaat M, van der Veer E, van Weissenbruch MM, Lafeber HN, Rotteveel J.

Clin Endocrinol (Oxf). 2014 Oct;81(4):551-8. doi: 10.1111/cen.12454. Epub 2014 May 5.

PMID:
24655054
40.

Clinical studies on bone-related outcome and the effect of TNF-α blocking therapy in ankylosing spondylitis.

Arends S, Spoorenberg A, Brouwer E, van der Veer E.

Curr Opin Rheumatol. 2014 May;26(3):259-68. doi: 10.1097/BOR.0000000000000053. Review.

PMID:
24625371
41.

Hematopoietic microRNA-126 protects against renal ischemia/reperfusion injury by promoting vascular integrity.

Bijkerk R, van Solingen C, de Boer HC, van der Pol P, Khairoun M, de Bruin RG, van Oeveren-Rietdijk AM, Lievers E, Schlagwein N, van Gijlswijk DJ, Roeten MK, Neshati Z, de Vries AA, Rodijk M, Pike-Overzet K, van den Berg YW, van der Veer EP, Versteeg HH, Reinders ME, Staal FJ, van Kooten C, Rabelink TJ, van Zonneveld AJ.

J Am Soc Nephrol. 2014 Aug;25(8):1710-22. doi: 10.1681/ASN.2013060640. Epub 2014 Mar 7.

42.

Vitamin D deficiency in risk groups living in tropical Curaçao.

Leenders TJ, van Eijndhoven FH, van der Veer E, Muskiet FA.

West Indian Med J. 2013 Mar;62(3):195-200.

PMID:
24564039
43.

Comparing tolerability and efficacy of generic versus brand alendronate: a randomized clinical study in postmenopausal women with a recent fracture.

van den Bergh JP, Bouts ME, van der Veer E, van der Velde RY, Janssen MJ, Geusens PP, Winkens B, Oldenhof NJ, van Geel TA.

PLoS One. 2013 Oct 21;8(10):e78153. doi: 10.1371/journal.pone.0078153. eCollection 2013.

44.

Severe HLA B27-associated uveitis complicated by hypotony, serous retinal detachment, and ciliochoroidal effusion.

van der Veer EG, Keunen JE, Rothova A.

Ocul Immunol Inflamm. 2014 Feb;22(1):23-6. doi: 10.3109/09273948.2013.828081. Epub 2013 Sep 24.

PMID:
24063542
45.

Daily physical activity in ankylosing spondylitis: validity and reliability of the IPAQ and SQUASH and the relation with clinical assessments.

Arends S, Hofman M, Kamsma YP, van der Veer E, Houtman PM, Kallenberg CG, Spoorenberg A, Brouwer E.

Arthritis Res Ther. 2013 Aug 23;15(4):R99. doi: 10.1186/ar4279.

46.

Quaking, an RNA-binding protein, is a critical regulator of vascular smooth muscle cell phenotype.

van der Veer EP, de Bruin RG, Kraaijeveld AO, de Vries MR, Bot I, Pera T, Segers FM, Trompet S, van Gils JM, Roeten MK, Beckers CM, van Santbrink PJ, Janssen A, van Solingen C, Swildens J, de Boer HC, Peters EA, Bijkerk R, Rousch M, Doop M, Kuiper J, Schalij MJ, van der Wal AC, Richard S, van Berkel TJ, Pickering JG, Hiemstra PS, Goumans MJ, Rabelink TJ, de Vries AA, Quax PH, Jukema JW, Biessen EA, van Zonneveld AJ.

Circ Res. 2013 Oct 12;113(9):1065-75. doi: 10.1161/CIRCRESAHA.113.301302. Epub 2013 Aug 20.

PMID:
23963726
47.

Scavenger receptor-AI-targeted iron oxide nanoparticles for in vivo MRI detection of atherosclerotic lesions.

Segers FM, den Adel B, Bot I, van der Graaf LM, van der Veer EP, Gonzalez W, Raynal I, de Winther M, Wodzig WK, Poelmann RE, van Berkel TJ, van der Weerd L, Biessen EA.

Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):1812-9. doi: 10.1161/ATVBAHA.112.300707. Epub 2013 Jun 6.

PMID:
23744990
48.

Higher mast cell load decreases the risk of Hymenoptera venom-induced anaphylaxis in patients with mastocytosis.

van Anrooij B, van der Veer E, de Monchy JG, van der Heide S, Kluin-Nelemans JC, van Voorst Vader PC, van Doormaal JJ, Oude Elberink JN.

J Allergy Clin Immunol. 2013 Jul;132(1):125-30. doi: 10.1016/j.jaci.2012.12.1578. Epub 2013 Mar 14.

PMID:
23498593
49.

Prevalence of indolent systemic mastocytosis in a Dutch region.

van Doormaal JJ, Arends S, Brunekreeft KL, van der Wal VB, Sietsma J, van Voorst Vader PC, Oude Elberink JN, Kluin-Nelemans JC, van der Veer E, de Monchy JG.

J Allergy Clin Immunol. 2013 May;131(5):1429-31.e1. doi: 10.1016/j.jaci.2012.10.015. Epub 2012 Dec 6. No abstract available.

PMID:
23219169
50.

Intrinsic directionality of migrating vascular smooth muscle cells is regulated by NAD(+) biosynthesis.

Yin H, van der Veer E, Frontini MJ, Thibert V, O'Neil C, Watson A, Szasz P, Chu MW, Pickering JG.

J Cell Sci. 2012 Dec 1;125(Pt 23):5770-80. doi: 10.1242/jcs.110262. Epub 2012 Sep 19.

Supplemental Content

Loading ...
Support Center